155 related articles for article (PubMed ID: 38073431)
1. Synthesis biological evaluation and molecular docking of isatin hybrids as anti-cancer and anti-microbial agents.
Altamimi M; Syed SA; Tuzun B; Alhazani MR; Alnemer O; Bari A
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2288548. PubMed ID: 38073431
[TBL] [Abstract][Full Text] [Related]
2. Isatin Bis-Indole and Bis-Imidazothiazole Hybrids: Synthesis and Antimicrobial Activity.
Bonvicini F; Locatelli A; Morigi R; Leoni A; Gentilomi GA
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144518
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 1H-1,2,3-Triazole-Linked Quinoline-Isatin Molecular Hybrids as Anti-Breast Cancer and Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Agents.
Awolade P; Cele N; Ebenezer O; Kerru N; Gummidi L; Gu L; Palma G; Kaur M; Singh P
Anticancer Agents Med Chem; 2021; 21(10):1228-1239. PubMed ID: 32990543
[TBL] [Abstract][Full Text] [Related]
4. Designing and Screening of New Schiff Bases of Isatins for Antibacterial Activity by In Silico Methods and Docking Studies.
Swathi K; Meghana B; Sowjanya K; Lakshmi Manasa G; Munemma R
Adv Exp Med Biol; 2021; 1339():249-255. PubMed ID: 35023112
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and pharmacological characterization of isatin and its derivatives: from structure to activity.
Pakravan P; Kashanian S; Khodaei MM; Harding FJ
Pharmacol Rep; 2013; 65(2):313-35. PubMed ID: 23744416
[TBL] [Abstract][Full Text] [Related]
6. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors.
Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A
Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, antimicrobial, antibiofilm and computational studies of isatin-semicarbazone tethered 1,2,3-triazoles.
Kumar A; Lal K; Kumar V; Murtaza M; Jaglan S; Paul AK; Yadav S; Kumari K
Bioorg Chem; 2023 Apr; 133():106388. PubMed ID: 36736034
[TBL] [Abstract][Full Text] [Related]
8. Isatin Hybrids and Their Pharmacological Investigations.
Varpe BD; Kulkarni AA; Jadhav SB; Mali AS; Jadhav SY
Mini Rev Med Chem; 2021; 21(10):1182-1225. PubMed ID: 33302835
[TBL] [Abstract][Full Text] [Related]
9. A Comprehensive Review of the Diverse Spectrum Activity of 1,2,3-Triazole-linked Isatin Hybrids.
Rohila Y; Sebastian S; Ansari A; Kumar D; Mishra DK; Gupta MK
Chem Biodivers; 2024 Apr; 21(4):e202301612. PubMed ID: 38332679
[TBL] [Abstract][Full Text] [Related]
10. Tackling Microbial Resistance with Isatin-Decorated Thiazole Derivatives: Design, Synthesis, and in vitro Evaluation of Antimicrobial and Antibiofilm Activity.
Kassab RM; Al-Hussain SA; Elleboudy NS; Albohy A; Zaki MEA; Abouzid KAM; Muhammad ZA
Drug Des Devel Ther; 2022; 16():2817-2832. PubMed ID: 36046334
[TBL] [Abstract][Full Text] [Related]
11. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
Yang M; Liu H; Zhang Y; Wang X; Xu Z
Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
[TBL] [Abstract][Full Text] [Related]
12. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies.
Singh H; Singh JV; Gupta MK; Saxena AK; Sharma S; Nepali K; Bedi PMS
Bioorg Med Chem Lett; 2017 Sep; 27(17):3974-3979. PubMed ID: 28797799
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic and anticancer activities of isatin and its derivatives: a comprehensive review from 2000-2008.
Vine KL; Matesic L; Locke JM; Ranson M; Skropeta D
Anticancer Agents Med Chem; 2009 May; 9(4):397-414. PubMed ID: 19442041
[TBL] [Abstract][Full Text] [Related]
14. Isatin dimers and their biological activities.
Zhang YZ; Du HZ; Liu HL; He QS; Xu Z
Arch Pharm (Weinheim); 2020 Mar; 353(3):e1900299. PubMed ID: 31985855
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity of novel 5-benzylidene-3-(3-phenylallylideneamino)imidazolidine-2,4-dione derivatives causing clinical pathogens: Synthesis and molecular docking studies.
Ali D; Alarifi S; Chidambaram SK; Radhakrishnan SK; Akbar I
J Infect Public Health; 2020 Dec; 13(12):1951-1960. PubMed ID: 33289644
[TBL] [Abstract][Full Text] [Related]
16. Isatin: A Scaffold with Immense Biodiversity.
Nath P; Mukherjee A; Mukherjee S; Banerjee S; Das S; Banerjee S
Mini Rev Med Chem; 2021; 21(9):1096-1112. PubMed ID: 33238872
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Molecular Docking and Evaluation of 1,3,4-Oxadiazole-Isobenzofuran Hybrids as Antimicrobial and Anticancer Agents.
Nayak S; Gaonkar SL; Hazra D; Chawla K; Hari G; Pai KSR; Guru BR; Hakimane SS
Chem Biodivers; 2022 May; 19(5):e202100956. PubMed ID: 35304823
[TBL] [Abstract][Full Text] [Related]
18. In-vitro Evaluation of Isatin Derivatives as Potent Anti-Breast Cancer Agents against MCF-7, MDA MB 231, MDA-MB 435 and MDA-MB 468 Breast Cancers Cell Lines: A Review.
Chauhan G; Pathak DP; Ali F; Dubey P; Khasimbi S
Anticancer Agents Med Chem; 2022; 22(10):1883-1896. PubMed ID: 34477529
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, Characterization, Molecular Docking, In Vitro Biological Evaluation and In Vitro Cytotoxicity Study of Novel Thiazolidine-4-One Derivatives as Anti-Breast Cancer Agents.
Kadhim ZY; Alqaraghuli HGJ; Abd MT
Anticancer Agents Med Chem; 2021; 21(17):2397-2406. PubMed ID: 33797379
[TBL] [Abstract][Full Text] [Related]
20. The anti-breast cancer potential of indole/isatin hybrids.
Wang R; Huang R; Yuan Y; Wang Z; Shen K
Arch Pharm (Weinheim); 2023 Nov; 356(11):e2300402. PubMed ID: 37650315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
